BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

462 related articles for article (PubMed ID: 14737724)

  • 1. Application of artificial neural network algorithm to detection of parathyroid adenoma.
    Stefaniak B; Cholewiński W; Tarkowska A
    Nucl Med Rev Cent East Eur; 2003; 6(2):111-7. PubMed ID: 14737724
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parathyroid imaging with pertechnetate plus perchlorate/MIBI subtraction scintigraphy: a fast and effective technique.
    Rubello D; Saladini G; Casara D; Borsato N; Toniato A; Piotto A; Bernante P; Pelizzo MR
    Clin Nucl Med; 2000 Jul; 25(7):527-31. PubMed ID: 10885694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parathyroid dual tracer subtraction scintigraphy: small regions method for quantitative assessment of parathyroid adenoma uptake.
    Koljević Marković A; Janković MM; Marković I; Pupić G; Džodić R; Delaloye AB
    Ann Nucl Med; 2014 Oct; 28(8):736-45. PubMed ID: 24947176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tc-99m sestamibi parathyroid gland scintigraphy: added value of Tc-99m pertechnetate thyroid imaging for increasing interpretation confidence and avoiding additional testing.
    Powell DK; Nwoke F; Goldfarb RC; Ongseng F
    Clin Imaging; 2013; 37(3):475-9. PubMed ID: 23102932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preoperative detection of parathyroid adenomas with Tc-99m MIBI and Tc-99m pertechnetate scintigraphy: histopathological and biochemical correlation with Tc-99m MIBI uptake.
    Akin M; Atasever T; Kurukahvecioglu O; Dogan M; Gokaslan D; Poyraz A; Koksal H; Taneri F
    Bratisl Lek Listy; 2009; 110(3):166-9. PubMed ID: 19507637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incremental diagnostic value of preoperative 99mTc-MIBI SPECT in patients with a parathyroid adenoma.
    Lorberboym M; Minski I; Macadziob S; Nikolov G; Schachter P
    J Nucl Med; 2003 Jun; 44(6):904-8. PubMed ID: 12791817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Parathyroid 99mTc-sestamibi scintigraphy: dual-tracer subtraction is superior to double-phase washout.
    Leslie WD; Dupont JO; Bybel B; Riese KT
    Eur J Nucl Med Mol Imaging; 2002 Dec; 29(12):1566-70. PubMed ID: 12458389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Technetium-99m-tetrofosmin for parathyroid scintigraphy: a comparison with sestamibi.
    Fjeld JG; Erichsen K; Pfeffer PF; Clausen OP; Rootwelt K
    J Nucl Med; 1997 Jun; 38(6):831-4. PubMed ID: 9189124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The role of scintigraphy with dual tracer and potassium perchlorate (99mTcO4 & KClO4/ MIBI) in primary hyperparathyroidism].
    Rubello D; Saladini G; Casara D
    Minerva Endocrinol; 2001 Mar; 26(1):13-21. PubMed ID: 11323563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Positive
    Dugonjić S; Šišić M; Radulović M; Ajdinović B
    Hell J Nucl Med; 2017; 20(1):46-50. PubMed ID: 28315908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of parathyroid imaging with technetium-99m-pertechnetate/sestamibi subtraction, double-phase technetium-99m-sestamibi and technetium-99m-sestamibi SPECT.
    Chen CC; Holder LE; Scovill WA; Tehan AM; Gann DS
    J Nucl Med; 1997 Jun; 38(6):834-9. PubMed ID: 9189125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation between serum calcium levels and dual-phase (99m)Tc-sestamibi parathyroid scintigraphy in primary hyperparathyroidism.
    Mshelia DS; Hatutale AN; Mokgoro NP; Nchabaleng ME; Buscombe JR; Sathekge MM
    Clin Physiol Funct Imaging; 2012 Jan; 32(1):19-24. PubMed ID: 22136277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of technetium-99m-MIBI, technetium-99m-tetrofosmin, ultrasound and MRI for localization of abnormal parathyroid glands.
    Ishibashi M; Nishida H; Hiromatsu Y; Kojima K; Tabuchi E; Hayabuchi N
    J Nucl Med; 1998 Feb; 39(2):320-4. PubMed ID: 9476944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical role of 99mTcO4/MIBI scan, ultrasound and intra-operative gamma probe in the performance of unilateral and minimally invasive surgery in primary hyperparathyroidism.
    Casara D; Rubello D; Pelizzo MR; Shapiro B
    Eur J Nucl Med; 2001 Sep; 28(9):1351-9. PubMed ID: 11585294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accurate planning of minimally invasive surgery of parathyroid adenomas by means of [(99m)Tc]MIBI SPECT.
    Massaro A; Cittadin S; Rampin L; Banti E; Rossi F; Pelizzo MR; Muzzio PC; Rubello D
    Minerva Endocrinol; 2007 Mar; 32(1):9-16. PubMed ID: 17353862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection and localization of parathyroid adenomas in patients with hyperparathyroidism using a single radionuclide imaging procedure with technetium-99m-sestamibi (double-phase study).
    Taillefer R; Boucher Y; Potvin C; Lambert R
    J Nucl Med; 1992 Oct; 33(10):1801-7. PubMed ID: 1328564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determinant role of Tc-99m MIBI SPECT in the localization of a retrotracheal parathyroid adenoma successfully treated by radioguided surgery.
    Rubello D; Casara D; Pagetta C; Piotto A; Pelizzo MR; Shapiro B
    Clin Nucl Med; 2002 Oct; 27(10):711-5. PubMed ID: 12352113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Technetium-99m methoxyisobutylisonitrile imaging for parathyroid adenoma: relationship to P-glycoprotein or multidrug resistance-related protein expression.
    Kao A; Shiau YC; Tsai SC; Wang JJ; Ho ST
    Eur J Nucl Med Mol Imaging; 2002 Aug; 29(8):1012-5. PubMed ID: 12173014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Papillary thyroid carcinoma associated with parathyroid adenoma detected by pertechnetate-MIBI subtraction scintigraphy.
    Rubello D; Toniato A; Pelizzo MR; Casara D
    Clin Nucl Med; 2000 Nov; 25(11):898-900. PubMed ID: 11079587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preoperative localization of parathyroid lesions. Value of 99mTc-MIBI tomography and factors influencing detection.
    Ansquer C; Mirallié E; Carlier T; Abbey-Huguenin H; Aubron F; Kraeber-Bodéré F
    Nuklearmedizin; 2008; 47(4):158-62. PubMed ID: 18690375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.